Short chain fatty acids inhibit endotoxin-induced uveitis and inflammatory responses of retinal astrocytes

Nu Chen,Jun Wu,Jingrui Wang,Niloofar Piri,Feilan Chen,Tong Xiao,Yuan Zhao,Deming Sun,Henry J Kaplan,Hui Shao,Henry J. Kaplan

DOI: https://doi.org/10.1016/j.exer.2021.108520

IF: 3.77

2021-05-01

Experimental Eye Research

Abstract:<p>Short chain fatty acids (SCFAs) are produced by gut microbiota as fermentation products of digestion-resistant oligosaccharides and fibers. Their primary roles are functioning as major energy sources for colon cells and assisting in gut homeostasis by immunomodulation. Recent evidence suggests that they affect various organs both at cellular and molecular levels, and regulate functions in distance sites including gene expression, cell proliferation, cell differentiation, apoptosis and inflammation. In this study, we examined whether SCFAs are present in the mouse eye and whether SCFAs affect inflammatory responses of the eye and retinal astrocytes (RACs). We observed that intra-peritoneal injected SCFAs were detected in the eye and reduced intraocular inflammation induced by lipopolysaccharide (LPS). Moreover, SCFAs displayed two disparate effects on LPS-stimulated RACs – namely, cytokine and chemokine production was reduced, but the ability to activate T cells was enhanced. Our results support the existence of gut-eye cross talk and suggest that SCFAs can cross the blood-eye-barrier via the systemic circulation. If applied at high concentrations, SCFAs may reduce inflammation and impact cellular functions in the intraocular milieu.</p>

ophthalmology

What problem does this paper attempt to address?

The paper attempts to address whether short-chain fatty acids (SCFAs) can enter the eye through systemic circulation and directly affect ocular inflammatory responses and the function of retinal astrocytes (RACs). Specifically, the study aims to explore the mechanisms of SCFAs in ocular inflammation, particularly in the model of Endotoxin-Induced Uveitis (EIU), and whether SCFAs can alleviate inflammatory responses and their specific effects.

The main findings of the paper include:
1. Short-chain fatty acids can enter the eye, brain, and liver tissues of mice after injection.
2. Injection of butyrate (C4) can significantly reduce the symptoms of acute anterior uveitis induced by lipopolysaccharide (LPS) in mice.
3. Butyrate and propionate (C3) can dose-dependently inhibit the production of various pro-inflammatory factors by RACs under LPS stimulation, such as IL-6, TNF-α, CXCL12, and CXCL1.
4. SCFAs reduce immune cell migration induced by RACs under LPS stimulation.
5. Although SCFAs reduce the secretion of pro-inflammatory factors by RACs, they enhance the activation and proliferation of IRBP-specific T cells.

These results support the communication between the gut and the eye and suggest that SCFAs may influence the intraocular environment by modulating immune responses.